Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes

被引:1
|
作者
Hajibandeh, Shahin [1 ]
Hajibandeh, Shahab [2 ]
Romman, Saleh [1 ]
Ghassemi, Nader [1 ]
Evans, Daisy [1 ]
Laing, Richard W. [1 ]
Durkin, Damien [1 ]
Athwal, Tejinderjit S. [1 ]
机构
[1] Univ Hosp North Midlands NHS Trust, Royal Stoke Univ Hosp, Dept Hepatobiliary & Pancreat Surg, Stoke On Trent, England
[2] Univ Hosp Wales, Dept Hepatobiliary & Pancreat Surg, Cardiff, Wales
关键词
Pancreatic resection; Renal cell carcinoma; Survival; INTERNATIONAL STUDY-GROUP; LONG-TERM SURVIVAL; SURGICAL-TREATMENT; DEFINITION; SURGERY; TUMORS; CLASSIFICATION; FISTULA;
D O I
10.1016/j.pan.2023.11.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims: To evaluate short-term clinical and long-term survival outcomes of pancreatic resection for pancreatic metastasis from renal cell carcinoma (RCC). Methods: A retrospective evaluation of patients undergoing pancreatic resection for metastasis from RCC over a 12-years period was conducted. Furthermore, a systematic search of electronic data sources and bibliographic reference lists were conducted to identify studies investigating the same clinical question. Short-term clinical and long-term survival outcomes were evaluated. Kaplan-Meier survival plots were constructed for survival outcomes. Cox-proportional regression analysis was performed to determine factors associated with survival. Finally, meta-analysis of survival outcomes was conducted using random-effects modelling. Results: Eighteen patients underwent pancreatic resections for RCC pancreatic metastasis within the study period. The mean age of the included patients was 63.8 +/- 8.0 years. There were 10(55.6 %) male and 8(44.4 %) female patients. Pancreatectomy was associated with 4(25.0 %) Clavien-Dindo (C-D) I, 5(31.3 %) C-D II, and 7(43.7 %) C-D III complications, 7(38.8 %) pancreatic fistula, 3(16.7 %) postpancreatectomy acute pancreatitis, 1(5.6 %) delayed gastric emptying, and 1(5.6 %) chyle leak. The mean length of hospital stay was 18 +/- 16.3 days. The median survival was 64 months (95 % CI 60-78). The 3-and 5-year disease-free survival rates were 83.3 % and 55.5 %, respectively. The 3-and 5-year survival rates were 100 % and 55.6 %, respectively. The pooled analyses of 553 patients demonstrated 3-and 5-year survival rates of 77.6 % and 60.7 %, respectively. Conclusions: Pancreatectomy for RCC metastasis is associated with acceptable short-term clinical and promising long-term survival outcomes. Considering the rarity of the entity, escalation of level of evidence in this context is challenging. (c) 2023 IAP and EPC. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 50 条
  • [41] Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis
    Wang, Guoqing
    Zhang, Xiaoyang
    Feng, Mengzhao
    Guo, Fuyou
    JOURNAL OF SURGICAL RESEARCH, 2018, 226 : 131 - 139
  • [42] Didactic surgical experience of thyroid metastasis from renal cell carcinoma: A case report
    Yamauchi, Moriyasu
    Kai, Keita
    Shibamiya, Natsuko
    Shimazu, Rintaro
    Monji, Mikio
    Suzuki, Kumiko
    Kakinoki, Hiroaki
    Tobu, Shohei
    Kuratomi, Yuichiro
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (15) : 1018 - 1023
  • [43] Survival Outcomes in Squamous Cell Carcinoma of the External Auditory Canal: A Systematic Review and Meta-Analysis
    Cazzador, Diego
    Franz, Leonardo
    Tealdo, Giulia
    Carobbio, Andrea Luigi Camillo
    Ferraro, Maria
    Mazzoni, Antonio
    Marioni, Gino
    Zanoletti, Elisabetta
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [44] The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis
    Xu, Yunze
    Qi, Yicheng
    Zhang, Jin
    Lu, Yongning
    Song, Jiajia
    Dong, Baijun
    Kong, Wen
    Xue, Wei
    Huang, Yiran
    TUMOR BIOLOGY, 2014, 35 (07) : 6633 - 6640
  • [45] Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: A systematic review and meta-analysis
    Nkemjika, Stanley
    Tokede, Oluwatosin
    Okosun, Ike S.
    Jadotte, Yuri
    Pigott, Therese
    CANCER EPIDEMIOLOGY, 2023, 86
  • [46] Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012
    Zhang, Yushi
    Yu, Hongyan
    Li, Hanzhong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (08) : 1327 - 1333
  • [47] Surgical management of hepato-pancreatic metastasis from renal cell carcinoma
    Nikolaos A Chatzizacharias
    Anais Rosich-Medina
    Khaled Dajani
    Simon Harper
    Emmanuel Huguet
    Siong S Liau
    Raaj K Praseedom
    Asif Jah
    World Journal of Gastrointestinal Oncology, 2017, (02) : 70 - 77
  • [48] Late solitary pancreatic metastasis from renal cell carcinoma
    Paz, A
    Koren, R
    Gal, R
    Wolloch, Y
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1996, 32 (12): : 1319 - 1321
  • [49] Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis
    Iwata, Takehiro
    Kimura, Shoji
    Foerster, Beat
    Abufaraj, Mohammad
    Karakiewicz, Pierre I.
    Preisser, Felix
    Nasu, Yasutomo
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (04) : 273 - 281
  • [50] Spontaneous rupture of pancreatic metastasis from renal cell carcinoma
    Kobayashi, Akitoshi
    Yamaguchi, Taketo
    Ishihara, Takeshi
    Tadenuma, Hiroshi
    Nakamura, Kazuyoshi
    Ohshima, Tadashi
    Sakaue, Nobuyuki
    Baba, Takeshi
    Yoshikawa, Masaharu
    Saisho, Hiromitsu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (11) : 696 - 699